Opioid Therapy in Chronic Pain

Physical Medicine and Rehabilitation Clinics of North America

Volumn 26, Issue 2, 2015, Pages 201-218

  Ballantyne, Jane C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Addiction; Dependence; Opioid dependence; Pain management

Indexed keywords

BUPRENORPHINE; CODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; LONG ACTING DRUG; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE; OXYMORPHONE; PETHIDINE; SHORT ACTING DRUG; TAPENTADOL; TESTOSTERONE; TRAMADOL;

ACCIDENT; ADDICTION; BACKACHE; BREAKTHROUGH PAIN; CHRONIC PAIN; COGNITIVE DEFECT; CONSTIPATION; DROWSINESS; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG OVERDOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; DRY SKIN; FALLING; FIBROMYALGIA; FRACTURE; HEADACHE; HUMAN; ILEUS; INFERTILITY; MUSCULOSKELETAL PAIN; NAUSEA; OPIATE ADDICTION; PAIN ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; RESPIRATORY ARREST; REVIEW; RISK REDUCTION; SCREENING; SHORT COURSE THERAPY; SUBSTANCE ABUSE; UNSPECIFIED SIDE EFFECT; URINALYSIS; ANALGESIA; OPIOID-RELATED DISORDERS; PAIN MEASUREMENT;

ANALGESICS, OPIOID; CHRONIC PAIN; HUMANS; OPIOID-RELATED DISORDERS; PAIN MANAGEMENT; PAIN MEASUREMENT; PATIENT SELECTION;

EID: 84929518842     PISSN: 10479651     EISSN: 15581381     Source Type: Journal    
DOI: 10.1016/j.pmr.2014.12.001     Document Type: Review

References (63)

1. Okie S. Aflood of opioids, a rising tide of deaths. NEngl J Med 2010, 363:1981-1985.
2. Center for Disease Control and Prevention (CDC) CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep 2012, 61:10-13.
3. Paulozzi L.J., Budnitz D.S., Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006, 15:618-627.
4. Deyo R.A., Mirza S.K., Turner J.A., et al. Overtreating chronic back pain: time to back off?. JAm Board Fam Med 2009, 22:62-68.
5. Deyo R.A., Patrick D.L. Hope or hype: the obsession with medical advances and the high cost of false promises 2005, AMACOM, New York.
6. Franklin G.M., Rahman E.A., Turner J.A., et al. Opioid use for chronic low back pain: a prospective, population-based study among injured workers in Washington state, 2002-2005. Clin J Pain 2009, 25:743-751.
7. Turner J.A., Franklin G., Fulton-Kehoe D., et al. ISSLS prize winner: early predictors of chronic work disability: a prospective, population-based study of workers with back injuries. Spine (Phila Pa 1976) 2008, 33:2809-2818.
8. Franklin G., Wickizer T., Coe N., et al. Workers' compensation: poor quality health care and the growing disability problem in the United States. Am J Ind Med 2014, [Epub ahead of print].
9. Franklin G.M. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology 2014, 83:1277-1284.
10. Sullivan M.D., Ballantyne J.C. What are we treating with chronic opioid therapy?. Arch Intern Med 2012, 172:433-434.
11. Martell B.A., O'Connor P.G., Kerns R.D., et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007, 146:116-127.
12. Chaparro L.E., Furlan A.D., Deshpande A., et al. Opioids compared with placebo or other treatments for chronic low back pain: an update of the Cochrane Review. Spine (Phila Pa 1976) 2014, 39:556-563.
13. Levin M. Opioids in headache. Headache 2014, 54:12-21.
14. Clauw D.J. Fibromyalgia: a clinical review. JAMA 2014, 311:1547-1555.
15. Peng X., Robinson R.L., Mease P., et al. Long-term evaluation of opioid treatment in fibromyalgia. Clin J Pain 2015, 31(1):7-13.
16. Turk D.C., Okifuji A. Pain terms and taxonomies. Bonica's management of pain 2010, 14-23. Lippincott Williams and Wilkins, Philadelphia. 4th edition. S.M. Fishman, J.C. Ballantyne, J.P. Rathmell (Eds.).
17. Braden J.B., Fan M.Y., Edlund M.J., et al. Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. JPain 2008, 9:1026-1035.
18. Korff M.V., Saunders K., Thomas Ray G., et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain 2008, 24:521-527.
19. Martin B.C., Fan M.Y., Edlund M.J., et al. Long-term chronic opioid therapy discontinuation rates from the TROUP study. JGen Intern Med 2011, 26:1450-1457.
20. Volinn E., Fargo J.D., Fine P.G. Opioid therapy for nonspecific low back pain and the outcome of chronic work loss. Pain 2009, 142:194-201.
21. Chou R., Fanciullo G.J., Fine P.G., et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. JPain 2009, 10:113-130.
22. Kreek M.J., Nielsen D.A., Butelman E.R., et al. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 2005, 8:1450-1457.
23. Butler S.F., Budman S.H., Fernandez K., et al. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004, 112:65-75.
24. Butler S.F., Budman S.H., Fernandez K.C., et al. Development and validation of the current opioid misuse measure. Pain 2007, 130:144-156.
25. Webster L., Webster R. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med 2005, 6:432-442.
26. Passik S.D., Kirsh K.L., Whitcomb L., et al. Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the pain assessment and documentation tool. JOpioid Manag 2005, 1:257-266.
27. Belgrade M.J., Schamber C.D., Lindgren B.R. The DIRE score: predicting outcomes of opioid prescribing for chronic pain. JPain 2006, 7:671-681.
28. Webster B.S., Verma S.K., Gatchel R.J. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine (Phila Pa 1976) 2007, 32:2127-2132.
29. Franklin G.M., Stover B.D., Turner J.A., et al. Early opioid prescription and subsequent disability among workers with back injuries: the Disability Risk Identification Study Cohort. Spine (Phila Pa 1976) 2008, 33:199-204.
30. Gross D.P., Stephens B., Bhambhani Y., et al. Opioid prescriptions in Canadian workers' compensation claimants: prescription trends and associations between early prescription and future recovery. Spine (Phila Pa 1976) 2009, 34:525-531.
31. Stover B.D., Turner J.A., Franklin G., et al. Factors associated with early opioid prescription among workers with low back injuries. JPain 2006, 7:718-725.
32. Franklin G.M., Mai J., Wickizer T., et al. Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002. Am J Ind Med 2005, 48:91-99.
33. Daniell H.W. Hypogonadism in men consuming sustained-action oral opioids. JPain 2002, 3:377-384.
34. Daniell H.W. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. JPain 2008, 9:28-36.
35. Finch P.M., Roberts L.J., Price L., et al. Hypogonadism in patients treated with intrathecal morphine. Clin J Pain 2000, 3:251-254.
36. Ballantyne J.C., LaForge S.L. Opioid dependence and addiction in opioid treated pain patients. Pain 2007, 129:235-255.
37. Ballantyne J.C., Sullivan M.D., Kolodny A. Opioid dependence vs addiction: a distinction without a difference?. Arch Intern Med 2012, 172:1342-1343.
38. Farrar J.T., Portenoy R.K., Berlin J.A., et al. Defining the clinically important difference in pain outcome measures. Pain 2000, 88:287-294.
39. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565-598.
40. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
41. Morasco B.J., Duckart J.P., Carr T.P., et al. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain 2010, 151:625-632.
42. Edlund M.J., Martin B.C., Fan M.Y., et al. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend 2010, 112:90-98.
43. Saunders K.W., Dunn K.M., Merrill J.O., et al. Relationship of opioid use and dosage levels to fractures in older chronic pain patients. JGen Intern Med 2010, 25:310-315.
44. Von Korff M., Merrill J.O., Rutter C.M., et al. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain 2011, 152:1256-1262.
45. Weisner C.M., Campbell C.I., Ray G.T., et al. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain 2009, 145:287-293.
46. Ballantyne J.C., Mao J. Opioid therapy for chronic pain. NEngl J Med 2003, 349:1943-1953.
47. Pasternak G.W. Multiple opiate receptors: deja vu all over again. Neuropharmacology 2004, 47(Suppl 1):312-323.
48. Chou R., Ballantyne J.C., Fanciullo G.J., et al. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. JPain 2009, 10:147-159.
49. Agency for Healthcare Research and Quality The effectiveness and risks of long-term opioid treatment of chronic pain 2014, US Department of Health and Human Services, Bethesda, Maryland, AHCPR Publication No 94-0592 March 1994.
50. Paulozzi L.J., Kilbourne E.M., Shah N.G., et al. Ahistory of being prescribed controlled substances and risk of drug overdose death. Pain Med 2012, 13:87-95.
51. Gomes T., Mamdani M.M., Dhalla I.A., et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011, 171:686-691.
52. Dunn K.M., Saunders K.W., Rutter C.M., et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010, 152:85-92.
53. Bohnert A.S., Valenstein M., Bair M.J., et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011, 305:1315-1321.
54. Fulton-Kehoe D., Garg R.K., Turner J.A., et al. Opioid poisonings and opioid adverse effects in workers in Washington State. Am J Ind Med 2013, 56:1452-1462.
55. Hall A.J., Logan J.E., Toblin R.L., et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008, 300:2613-2620.
56. Ballantyne J.C., Shin N.S. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain 2008, 24:469-478.
57. Ballantyne JC. Clinical and administrative data review presented to FDA May 30th and 31st 2012. 2012. Available at:. http://www.fda.gov/downloads/Drugs/NewsEvents/UCM307844.pdf.
58. Bruehl S., Apkarian A.V., Ballantyne J.C., et al. Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. JPain 2013, 14:103-113.
59. Eriksen J., Sjogren P., Bruera E., et al. Critical issues on opioids in chronic non-cancer pain. An epidemiological study. Pain 2006, 125:172-179.
60. Dillie K.S., Fleming M.F., Mundt M.P., et al. Quality of life associated with daily opioid therapy in a primary care chronic pain sample. JAm Board Fam Med 2008, 21:108-117.
61. Fishbain D.A., Cole B., Lewis J., et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addictionand/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008, 9:444-459.
62. Fishbain D.A., Rosomoff H.L., Rosomoff R.S. Drug abuse, dependence and addiction in chronic pain patients. Clin J Pain 1992, 8:77-85.
63. Butler S.F., Budman S.H., Fernandez K.C., et al. Cross-Validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R). JAddict Med 2009, 3:66-73.